Enjoy complimentary customisation on priority with our Enterprise License!
The Gastrointestinal Over-The-Counter (OTC) Drugs Market size is forecasted to increase by USD 5.27 million, at a CAGR of 5.55% between 2023 and 2028. The market is experiencing significant growth due to several key trends and factors. The rise in the prevalence of gastrointestinal disorders, driven by unhealthy diets, sedentary lifestyles, and aging populations, is fueling the demand for over-the-counter (OTC) drugs. Furthermore, the increasing adoption of online platforms for purchasing OTC drugs offers convenience and accessibility to consumers, expanding market reach. However, the market also faces challenges such as the risk of incorrect self-diagnosis and consumption of wrong medications, which can lead to adverse health effects. To mitigate this risk, there is a growing need for consumer education and awareness programs, as well as regulatory initiatives to ensure the safety and efficacy of OTC gastrointestinal drugs.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.